{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:43:22Z","timestamp":1782175402319,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.sapharm.2017.05.015","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T06:00:39Z","timestamp":1496124039000},"page":"997-1003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The TOronto ThromboProphylaxis Patient Safety Initiative (TOPPS): A cluster randomised trial"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6124-1882","authenticated-orcid":false,"given":"Artemis","family":"Diamantouros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Papastavros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"U.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0162-7027","authenticated-orcid":false,"given":"Merrick","family":"Zwarenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Geerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2017.05.015_bib1","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1001\/jama.290.14.1868","article-title":"Excess length of stay, charges and mortality attributable to medical injuries during hospitalization","volume":"290","author":"Zhan","year":"2003","journal-title":"JAMA"},{"issue":"6778","key":"10.1016\/j.sapharm.2017.05.015_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/bmj.302.6778.709","article-title":"Incidence of venous thromboembolism verified by necropsy over 30 years","volume":"302","author":"Lindblad","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2017.05.015_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archinte.159.5.445","article-title":"Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study","volume":"159","author":"Heit","year":"1999","journal-title":"Arch Intern Med"},{"issue":"6 Suppl","key":"10.1016\/j.sapharm.2017.05.015_bib4","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of chest physicians evidence-based clinical practice guidelines","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.sapharm.2017.05.015_bib5","unstructured":"National Institute for Health and Care Excellence (UK). Venous Thromboembolism: reducing the risk for patients in hospital. Published January 2010. Last updated June 2015. Available from: https:\/\/www.nice.org.uk\/guidance\/cg92."},{"key":"10.1016\/j.sapharm.2017.05.015_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1076029612474840","article-title":"Prevention and treatment of venous thromboembolism: international consensus statement (guidelines according to scientific evidence)","volume":"19","author":"Nicolaides","year":"2013","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2 Suppl","key":"10.1016\/j.sapharm.2017.05.015_bib7","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.sapharm.2017.05.015_bib8","series-title":"Making Health Care Safer: A Critical Analysis of Patient Safety Practices","year":"2001"},{"key":"10.1016\/j.sapharm.2017.05.015_bib9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1378\/chest.06-2993","article-title":"Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the international medical prevention registry on venous thromboembolism","volume":"132","author":"Tapson","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.sapharm.2017.05.015_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/archinte.160.3.334","article-title":"Prevention of venous thromboembolism. Adherence to the 1995 American College of chest physicians consensus guidelines for surgical patients","volume":"160","author":"Stratton","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2017.05.015_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1378\/chest.07-0430","article-title":"Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent","volume":"132","author":"Piazza","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.sapharm.2017.05.015_bib12","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/j.1538-7836.2008.03172.x","article-title":"Clinical predictors of prophylaxis use prior to the onset of acute venous thromboembolism in hospitalized patients: SWIss Venous ThromboEmbolism Registry (SWIVTER)","volume":"6","author":"Kucher","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.sapharm.2017.05.015_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2006.01.011","article-title":"Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada","volume":"119","author":"Kahn","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.sapharm.2017.05.015_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjcard.2003.09.057","article-title":"A\u00a0prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis","volume":"2","author":"Goldhaber","year":"2004","journal-title":"Am J Cardiol"},{"issue":"Suppl","key":"10.1016\/j.sapharm.2017.05.015_bib15","first-page":"36","article-title":"The cost-effectiveness of prevention of post-operative thromboembolism","volume":"556","author":"Bergqvist","year":"1990","journal-title":"Acta Chir Scand"},{"key":"10.1016\/j.sapharm.2017.05.015_bib16","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1538-7836.2007.02650.x","article-title":"Thromboprophylaxis rates in US medical centers: success or failure?","volume":"5","author":"Amin","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.sapharm.2017.05.015_bib17","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/j.thromres.2013.03.014","article-title":"Venous thromboemboprophylaxis duration and adherence to international guidelines in patients undergoing major orthopedic surgery: results of an international, longitudinal, observational DEIMOS registry","volume":"131","author":"Arcelus","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.sapharm.2017.05.015_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/01.sla.0000154120.96169.99","article-title":"A\u00a0systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals","volume":"241","author":"Tooher","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.sapharm.2017.05.015_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3810\/hp.2010.02.284","article-title":"Venous thromboembolism prevention: a systematic review of methods to improve prophylaxis and decrease events in the hospitalized patient","volume":"38","author":"Mahan","year":"2010","journal-title":"Hosp Pract"},{"key":"10.1016\/j.sapharm.2017.05.015_bib20","article-title":"Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism","volume":"7","author":"Kahn","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"10.1016\/j.sapharm.2017.05.015_bib21","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.sapharm.2017.05.015_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1076029611405186","article-title":"Venous thromboembolism pharmacy management program with an active, multifaceted approach reduces preventable venous thromboembolism and increases appropriate prophylaxis","volume":"18","author":"Mahan","year":"2012","journal-title":"Clin Appl Throm Hemost"},{"key":"10.1016\/j.sapharm.2017.05.015_bib23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/qshc.2007.024844","article-title":"A\u00a0model for increasing patient safety in the intensive care unit: increasing the implementation rates of proven safety measures","volume":"18","author":"Krimsky","year":"2009","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.sapharm.2017.05.015_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/qshc.2007.024778","article-title":"Improving the use of venous thromboembolism prophylaxis in an Australian teaching hospital","volume":"18","author":"Gallagher","year":"2009","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.sapharm.2017.05.015_bib25","first-page":"755","article-title":"Effect of a clinical pharmacy education program on improvement in the quantity and quality of venous thromboembolism prophylaxis for medically ill patients","volume":"11","author":"Dobesh","year":"2005","journal-title":"J\u00a0Manag Care Pharm"},{"key":"10.1016\/j.sapharm.2017.05.015_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11606-010-1296-y","article-title":"Venous thromboembolism prophylaxis among medical patients at US hospitals","volume":"25","author":"Rothberg","year":"2010","journal-title":"J\u00a0Gen Int Med"},{"issue":"9610","key":"10.1016\/j.sapharm.2017.05.015_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(08)60202-0","article-title":"Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study","volume":"371","author":"Cohen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2017.05.015_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11239-007-0084-y","article-title":"Underutilization of venous thromboemoblism prophylaxis in medical patients in a tertiary care center","volume":"26","author":"Masroujeh","year":"2008","journal-title":"J\u00a0Thromb Thrombolys"},{"key":"10.1016\/j.sapharm.2017.05.015_bib29","series-title":"Required Organizational Practices Handbook","author":"Accreditation Canada","year":"2015"},{"key":"10.1016\/j.sapharm.2017.05.015_bib30","doi-asserted-by":"crossref","first-page":"e3935","DOI":"10.1136\/bmj.e3935","article-title":"Lessons from the Johns Hopkins multi-disciplinary venous thromboembolism (VTE) prevention collaborative","volume":"344","author":"Streiff","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2017.05.015_bib31","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2146\/ajhp070598","article-title":"Development and implementation of a program to assess medical patients' need for venous thromboembolism prophylaxis","volume":"65","author":"Sobieraj","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.sapharm.2017.05.015_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jhm.562","article-title":"Optimizing prevention of hospital-acquired (HA) venous thromboembolism (VTE): prospective validation of a VTE risk assessment model (RAM)","volume":"5","author":"Maynard","year":"2010","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.sapharm.2017.05.015_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2146\/ajhp070660","article-title":"Implementation of a multidisciplinary, pharmacy-led, thromboprophylaxis program in total-joint arthroplasty patients","volume":"66","author":"Cronin","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.sapharm.2017.05.015_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jhm.291","article-title":"Innovative approaches to increase deep vein thrombosis prophylaxis rate resulting in a decrease in hospital-acquired deep vein thrombosis at a tertiary-care teaching hospital","volume":"3","author":"Bullock-Palmer","year":"2008","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.sapharm.2017.05.015_bib35","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2146\/ajhp070595","article-title":"Pharmacist-led program to improve venous thromboembolism prophylaxis in a community hospital","volume":"65","author":"Bauer","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.sapharm.2017.05.015_bib36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/intqhc\/mzm034","article-title":"Intervention targeted at nurses to improve venous thromboprophylaxis","volume":"19","author":"Labarere","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.sapharm.2017.05.015_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1472-6963-13-203","article-title":"The implementation of NICE guidance on venous thromboemboembolism risk assessment and prophylaxis: a before-after observational study to assess the impact of patient safety across four hospitals in England","volume":"13","author":"Bateman","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.sapharm.2017.05.015_bib38","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1378\/chest.13-0267","article-title":"Comprehensive VTE prevention program incorporating mandatory risk assessment reduces the incidence of hospital-acquired thrombosis","volume":"144","author":"Roberts","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.sapharm.2017.05.015_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/phar.1244","article-title":"Role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism","volume":"33","author":"Dobesh","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.sapharm.2017.05.015_bib40","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1136\/heartjnl-2013-304479","article-title":"Fatal venous thromboembolism associated with hospital admission: a cohort study to assess the impact of a national risk assessment target","volume":"99","author":"Lester","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.sapharm.2017.05.015_bib41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ajh.23450","article-title":"Impact of a venous thromboembolism prophylaxis \u201csmart order set\u201d: improved compliance, fewer events","volume":"88","author":"Zeidan","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.sapharm.2017.05.015_bib42","first-page":"558","article-title":"Optimizing the prevention of venous thromboembolism: recent quality initiatives and strategies to drive improvement","volume":"35","author":"Amin","year":"2009","journal-title":"Jt Comm J Qual Pat Saf"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741116303369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741116303369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:12:25Z","timestamp":1761556345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741116303369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1551741116303369"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2017.05.015","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The TOronto ThromboProphylaxis Patient Safety Initiative (TOPPS): A cluster randomised trial","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2017.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}